Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision history shows an addition of v3.5.0 and a deletion of v3.4.3. These entries document the version updates for the page.
    Difference
    0.1%
    Check dated 2026-03-18T16:45:29.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No user-facing content or functionality changes are introduced.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:31.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Latest history entry adds Contacts/Locations and Study Status to the study record. A deletion was recorded on 2025-09-16.
    Difference
    0.3%
    Check dated 2026-03-04T11:36:39.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added a new revision entry 'Revision: v3.4.2' to the version history. Removed the government funding lapse notice; these changes do not affect the study record content.
    Difference
    0.4%
    Check dated 2026-02-11T05:26:40.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added a site-wide notice about potential delays due to a lapse in government funding and the NIH Clinical Center’s open status, and updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T04:58:24.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    UI updates add a Show glossary option and explain color-coding for additions/deletions (green/red), and the page revision label shifts from v3.3.4 to v3.4.0 with capitalization tweaks in 'No FEAR Act data'.
    Difference
    0.5%
    Check dated 2026-01-28T03:14:22.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.